百奥赛图-B(02315)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02315 百奥赛图-B

未开盘 07-14 16:08:21

20.300

-0.850

-4.02%

最高21.450	最低19.960	成交量31.60万
今开21.200	昨收21.150	日振幅7.04%
总市值81.08亿	流通市值22.53亿	总股本3.99亿
成交额647.11万	换手率0.28%	流通股本1.11亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02315","market":"HK","secType":"STK","nameCN":"百奥赛图-B","latestPrice":20.3,"timestamp":1752480501042,"preClose":21.15,"halted":0,"volume":316000,"delay":0,"floatShares":111000000,"shares":399398420,"eps":0.09224036686056096,"marketStatus":"未开盘","change":-0.85,"latestTime":"07-14 16:08:21","open":21.2,"high":21.45,"low":19.96,"amount":6471095,"amplitude":0.070449,"askPrice":20.55,"askSize":2500,"bidPrice":20.3,"bidSize":500,"shortable":0,"etf":0,"ttmEps":0.09224036686056096,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1752543000000},"marketStatusCode":0,"adr":0,"listingDate":1661961600000,"exchange":"SEHK","adjPreClose":21.15,"openAndCloseTimeList":[[1752456600000,1752465600000],[1752469200000,1752480000000]],"volumeRatio":1.051581,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02315","defaultTab":"news","newsList":[{"id":"2551979202","title":"百奥赛图-B盘中异动 股价大跌5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551979202","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551979202?lang=zh_cn&edition=full","pubTime":"2025-07-14 13:28","pubTimestamp":1752470892,"startTime":"0","endTime":"0","summary":"2025年07月14日下午盘13时28分，百奥赛图-B股票出现波动，股价快速下挫5.20%。截至发稿，该股报20.050港元/股，成交量16.05万股，换手率0.14%，振幅6.62%。百奥赛图-B股票所在的生物技术行业中，整体跌幅为1.25%。百奥赛图-B公司简介：北京百奥赛图基因生物技术有限公司是一家主要从事药物开发业务及临床前研究中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714132813a44907fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714132813a44907fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02315"],"gpt_icon":0},{"id":"2551130912","title":"2025年医保政策与产业动态：产业布局升级与行业监管强化","url":"https://stock-news.laohu8.com/highlight/detail?id=2551130912","media":"报告大厅","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551130912?lang=zh_cn&edition=full","pubTime":"2025-07-13 08:05","pubTimestamp":1752365100,"startTime":"0","endTime":"0","summary":"中国报告大厅网讯，随着国家医疗保障体系的不断完善，2025年医保相关政策及医药产业发展呈现显著变化。国家医保局、药监局等机构通过政策引导与严格监管，进一步优化药品供给结构，并强化了对违法违规行为的打击力度。数据显示，2025年目录调整将直接影响超万种药品的市场准入资格。总结2025年医保政策与产业布局呈现多维度深化态势：目录动态调整优化资源配置、监管强化保障行业规范、资本助力推动技术创新。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071308112797a3ed86&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071308112797a3ed86&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688235","02315","ONC","BK0239","06160"],"gpt_icon":0},{"id":"2550961135","title":"百奥赛图-B盘中异动 临近收盘股价大跌5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550961135","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550961135?lang=zh_cn&edition=full","pubTime":"2025-07-10 15:50","pubTimestamp":1752133819,"startTime":"0","endTime":"0","summary":"2025年07月10日临近收盘15时50分，百奥赛图-B股票出现波动，股价急速跳水5.30%。截至发稿，该股报20.550港元/股，成交量25.4万股，换手率0.23%，振幅7.60%。百奥赛图-B股票所在的生物技术行业中，整体跌幅为0.33%。百奥赛图-B公司简介：北京百奥赛图基因生物技术有限公司是一家主要从事药物开发业务及临床前研究中国公司。2024年，当百奥赛图在财报中高调宣布“阶段性扭亏为盈”时，董事长沈月雷的薪酬从205万元飙升至425.9万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071015502097a0ad8d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071015502097a0ad8d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02315","BK1161"],"gpt_icon":0},{"id":"2550661203","title":"百奥赛图与百济神州达成抗体分子许可协议，加速创新药物开发","url":"https://stock-news.laohu8.com/highlight/detail?id=2550661203","media":"美国商业资讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550661203?lang=zh_cn&edition=full","pubTime":"2025-07-10 00:00","pubTimestamp":1752076800,"startTime":"0","endTime":"0","summary":"-- 百奥赛图，一家创新技术驱动新药研发的国际性生物技术公司，今日宣布与全球肿瘤治疗创新公司百济神州达成抗体分子的全球许可协议。根据协议条款，百济神州将向百奥赛图支付首付款。关于百济神州百济神州是一家注册地位于瑞士的全球肿瘤治疗创新公司，专注于为全世界的癌症患者研发创新抗肿瘤药物。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710080113a6a041c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710080113a6a041c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06978","02315","06160","688235","LU2328871848.SGD","LU0307460666.USD","BK1500","BK1583","ONC","BK1161","LU1969619763.USD","BK1574","LU0588546209.SGD","BK1588"],"gpt_icon":0},{"id":"2550502024","title":"百奥赛图-B盘中异动 急速上涨5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550502024","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550502024?lang=zh_cn&edition=full","pubTime":"2025-07-09 13:41","pubTimestamp":1752039668,"startTime":"0","endTime":"0","summary":"2025年07月09日下午盘13时41分，百奥赛图-B股票出现波动，股价快速拉升5.33%。百奥赛图-B股票所在的生物技术行业中，整体涨幅为1.85%。百奥赛图-B公司简介：北京百奥赛图基因生物技术有限公司是一家主要从事药物开发业务及临床前研究中国公司。2024年，当百奥赛图在财报中高调宣布“阶段性扭亏为盈”时，董事长沈月雷的薪酬从205万元飙升至425.9万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709134109a43f8cde&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709134109a43f8cde&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02315","BK1161"],"gpt_icon":0},{"id":"2550506386","title":"百奥赛图IPO：18亿亏损下的高管薪酬狂欢与研发断崖","url":"https://stock-news.laohu8.com/highlight/detail?id=2550506386","media":"中金在线","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550506386?lang=zh_cn&edition=full","pubTime":"2025-07-09 10:40","pubTimestamp":1752028839,"startTime":"0","endTime":"0","summary":"一家累计亏损18亿元的 生物医药 企业，高管年薪却集体突破200万元，研发投入腰斩的同时，实控人薪酬翻倍。2024年，当百奥赛图在财报中高调宣布“阶段性扭亏为盈”时，董事长沈月雷的薪酬从205万元飙升至425.9万元。一边是累计未弥补亏损高达18.4亿元的财务黑洞，一边是高管薪酬逆势暴涨的狂欢。百奥赛图的资金链已紧绷到临界点。此次IPO募资缩水7亿元后，11.85亿元的募资额更像是杯水车薪。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709105044a43f3e8e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709105044a43f3e8e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02315","BK1161"],"gpt_icon":0},{"id":"2549303773","title":"百奥赛图-B盘中异动 早盘股价大跌5.22%报21.800港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2549303773","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549303773?lang=zh_cn&edition=full","pubTime":"2025-07-07 10:09","pubTimestamp":1751854163,"startTime":"0","endTime":"0","summary":"2025年07月07日早盘10时09分，百奥赛图-B股票出现异动，股价大幅跳水5.22%。截至发稿，该股报21.800港元/股，成交量1.65万股，换手率0.01%，振幅3.91%。资金方面，该股资金流入6.7075万港元，流出24.495万港元。百奥赛图-B股票所在的生物技术行业中，整体跌幅为1.03%。其相关个股中，正大企业国际、思路迪医药股份、创胜集团-B涨幅较大，振幅较大的相关个股有北海康成-B、正大企业国际、药捷安康-B，振幅分别为20.29%、11.37%、10.31%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707100924979c7918&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707100924979c7918&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02315","BK1161"],"gpt_icon":0},{"id":"2549371410","title":"百奥赛图-B(02315.HK)获LAKE BLEU CAPITAL (Hong Kong)增持8.15万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2549371410","media":"格隆汇","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549371410?lang=zh_cn&edition=full","pubTime":"2025-07-07 06:54","pubTimestamp":1751842447,"startTime":"0","endTime":"0","summary":"格隆汇7月7日丨根据联交所最新权益披露资料显示，2025年7月3日，百奥赛图-B(02315.HK)获LAKE BLEU CAPITAL (Hong Kong) LIMITED在场内以每股均价23.392港元增持8.15万股，涉资约190.64万港元。增持后，LAKE BLEU CAPITAL (Hong Kong) LIMITED最新持股数目为561.16万股，持股比例由4.99%上升至5.07%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/07/07065451518670.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["IE0031619046.USD","IE00B19Z4B17.USD","IE00B7SZL793.SGD","BK1161","BK4568","02315","IE00B66KJ199.SGD","BLEU","BK4202","LAKE"],"gpt_icon":0},{"id":"2548393299","title":"LAKE BLEU CAPITAL (Hong Kong) LIMITED增持百奥赛图(02315)8.15万股 每股作价约23.39港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548393299","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548393299?lang=zh_cn&edition=full","pubTime":"2025-07-04 19:05","pubTimestamp":1751627103,"startTime":"0","endTime":"0","summary":"7月3日，LAKE BLEU CAPITAL (Hong Kong) LIMITED增持百奥赛图(02315)8.15万股，平均每股作价为23.392港元，总金额约为190.64万港元。","market":"sh","thumbnail":"https://img.zhitongcaijing.com/image/20250704/20250704190513_61183.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20250704/20250704190513_61183.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1314177.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["IE00B19Z4B17.USD","IE0031619046.USD","BK1161","02315","LAKE","IE00B7SZL793.SGD","BK4568","BLEU","BK4202","IE00B66KJ199.SGD"],"gpt_icon":0},{"id":"2548332728","title":"百奥赛图-B盘中异动 快速下跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548332728","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548332728?lang=zh_cn&edition=full","pubTime":"2025-07-04 10:03","pubTimestamp":1751594622,"startTime":"0","endTime":"0","summary":"2025年07月04日早盘10时03分，百奥赛图-B股票出现波动，股价大幅跳水5.08%。截至发稿，该股报22.400港元/股，成交量12.1万股，换手率0.11%，振幅3.60%。百奥赛图-B股票所在的生物技术行业中，整体涨幅为0.41%。百奥赛图-B公司简介：北京百奥赛图基因生物技术有限公司是一家主要从事药物开发业务及临床前研究中国公司。同时，公司正在业绩波动、研发投入持续萎缩及与百奥赛图的专利纠纷渐入关键阶段的多重挑战中寻找平衡。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704100343a4ce6503&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704100343a4ce6503&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02315","BK1161"],"gpt_icon":0},{"id":"2548830293","title":"百奥赛图-B盘中异动 早盘急速上涨7.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548830293","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548830293?lang=zh_cn&edition=full","pubTime":"2025-07-02 09:32","pubTimestamp":1751419930,"startTime":"0","endTime":"0","summary":"2025年07月02日早盘09时32分，百奥赛图-B股票出现波动，股价快速上涨7.11%。截至发稿，该股报24.100港元/股，成交量1.65万股，换手率0.01%，振幅7.11%。百奥赛图-B股票所在的生物技术行业中，整体涨幅为0.95%。其相关个股中，华昊中天医药-B、加科思-B、荣昌生物涨幅较大，振幅较大的相关个股有华昊中天医药-B、科笛-B、百奥赛图-B，振幅分别为51.47%、9.18%、7.11%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702093211a4c9f549&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702093211a4c9f549&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02315","BK1161"],"gpt_icon":0},{"id":"2546733860","title":"百奥赛图-B06月26日遭主力抛售44.9万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546733860","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546733860?lang=zh_cn&edition=full","pubTime":"2025-06-26 20:26","pubTimestamp":1750940760,"startTime":"0","endTime":"0","summary":"06月26日, 百奥赛图-B股价跌1.12%，报收22.15元，成交金额784.3万元，换手率0.32%，振幅5.13%，量比0.57。百奥赛图-B今日主力资金净流出44.9万元，上一交易日主力净流出50.5万元。该股近5个交易日上涨2.55%，主力资金累计净流出62.5万元；近20日主力资金累计净流入380.2万元，其中净流入天数为6日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626203513a71ee599&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626203513a71ee599&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02315","BK1161"],"gpt_icon":0},{"id":"2546604632","title":"百奥赛图-B午后涨超8% 公司近期宣布回购计划 RenMab技术平台获日本专利授权","url":"https://stock-news.laohu8.com/highlight/detail?id=2546604632","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546604632?lang=zh_cn&edition=full","pubTime":"2025-06-25 14:04","pubTimestamp":1750831476,"startTime":"0","endTime":"0","summary":"百奥赛图-b午后涨超8%，截至发稿，涨5.52%，报22.95港元，成交额2651.78万港元。消息面上，6月13日，百奥赛图公布，未来24个月内，拟以不超过5,000万元的内部自有资金购买及或购回H股。公司可根据市场状况及的资本管理需求，注销有关购回股份或将其作为库存股份持有，以及用购买H股履行股份奖励。此外，百奥赛图自主研发的全人抗体小鼠RenMab平台关键技术近期获得由日本专利局颁发的发明专利证书。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625141458a4bcbe67&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625141458a4bcbe67&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02315","BK1161"],"gpt_icon":0},{"id":"2546262952","title":"百奥赛图-B盘中异动 下午盘大幅上涨5.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546262952","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546262952?lang=zh_cn&edition=full","pubTime":"2025-06-25 13:05","pubTimestamp":1750827944,"startTime":"0","endTime":"0","summary":"2025年06月25日下午盘13时05分，百奥赛图-B股票出现波动，股价快速拉升5.52%。百奥赛图-B股票所在的生物技术行业中，整体跌幅为0.20%。其相关个股中，荣昌生物、百奥赛图-B、基石药业-B涨幅较大，振幅较大的相关个股有北海康成-B、药明巨诺-B、来凯医药-B，振幅分别为19.40%、13.50%、10.56%。百奥赛图-B公司简介：北京百奥赛图基因生物技术有限公司是一家主要从事药物开发业务及临床前研究中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625130544952aa2cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625130544952aa2cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02315","BK1161"],"gpt_icon":0},{"id":"1136712238","title":"学习时报：要加快创新药研发，完善多层次资本市场对医药企业的支持","url":"https://stock-news.laohu8.com/highlight/detail?id=1136712238","media":"学习时报","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1136712238?lang=zh_cn&edition=full","pubTime":"2025-06-25 08:47","pubTimestamp":1750812468,"startTime":"0","endTime":"0","summary":"我国创新药需要加强基础研究，深化审评审批改革，完善多层次资本市场对医药企业的支持，优化投融资体系，强化人才培养引进，深化国际合作，推动创新药高质量发展。完善多层次资本市场对医药企业的支持，继续发挥科创板、创业板对未盈利生物医药企业上市融资的政策优势；对已上市创新药企业，支持其再融资募资用于新药研发。一方面，创新药是应对重大疾病挑战的根本出路和维护国家医药安全的战略基石。","market":"sh","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"2c311560e6543cd83c4c3858bcff515b","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://paper.cntheory.com/cntheory/2025-06/25/content_9952741.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"学习时报：要加快创新药研发，完善多层次资本市场对医药企业的支持","news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"lsy1750812533947","symbols":["02410","02315","09995"],"gpt_icon":0},{"id":"2545420183","title":"百奥赛图-B盘中异动 早盘股价大涨5.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2545420183","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545420183?lang=zh_cn&edition=full","pubTime":"2025-06-24 10:12","pubTimestamp":1750731169,"startTime":"0","endTime":"0","summary":"2025年06月24日早盘10时12分，百奥赛图-B股票出现波动，股价急速拉升5.53%。截至发稿，该股报21.000港元/股，成交量6.05万股，换手率0.05%，振幅5.63%。百奥赛图-B股票所在的生物技术行业中，整体涨幅为0.74%。百奥赛图-B公司简介：北京百奥赛图基因生物技术有限公司是一家主要从事药物开发业务及临床前研究中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624101249a71a5852&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624101249a71a5852&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02315"],"gpt_icon":0},{"id":"2545571454","title":"百奥赛图-B盘中异动 快速下跌5.23%报20.850港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545571454","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545571454?lang=zh_cn&edition=full","pubTime":"2025-06-23 09:35","pubTimestamp":1750642547,"startTime":"0","endTime":"0","summary":"2025年06月23日早盘09时35分，百奥赛图-B股票出现异动，股价急速下挫5.23%。截至发稿，该股报20.850港元/股，成交量1.05万股，换手率0.01%，振幅2.27%。资金方面，该股资金流入0港元，流出31.5625万港元。百奥赛图-B股票所在的生物技术行业中，整体跌幅为0.54%。百奥赛图-B公司简介：北京百奥赛图基因生物技术有限公司是一家主要从事药物开发业务及临床前研究中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623093547952747fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623093547952747fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02315","BK1161"],"gpt_icon":0},{"id":"2544148610","title":"百奥赛图-B盘中异动 下午盘股价大跌6.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2544148610","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544148610?lang=zh_cn&edition=full","pubTime":"2025-06-20 14:38","pubTimestamp":1750401506,"startTime":"0","endTime":"0","summary":"2025年06月20日下午盘14时38分，百奥赛图-B股票出现波动，股价大幅下跌6.02%。百奥赛图-B股票所在的生物技术行业中，整体跌幅为0.26%。目前，百奥赛图已经与全球前十大药企全部建立了稳定的合作关系，海外业务销售占比接近70%，全球影响力持续攀升。同时，百奥赛图已于2025年初完成了AI驱动抗体药物研发平台的本地化部署，并实现其与“千鼠万抗”计划的全面协同。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250620143827a713eb8b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250620143827a713eb8b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02315","BK1161"],"gpt_icon":0},{"id":"2544978387","title":"百奥赛图(02315)靠持续创新跑通Biotech商业模式 双轮驱动打开成长天花板 迎来估值重塑","url":"https://stock-news.laohu8.com/highlight/detail?id=2544978387","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544978387?lang=zh_cn&edition=full","pubTime":"2025-06-18 17:42","pubTimestamp":1750239754,"startTime":"0","endTime":"0","summary":"截至6月18日，百奥赛图股价从去年11月底部的5.6港币一路飙升至21.8港币，涨幅近300%，今年年内涨幅也已超过150%，远远跑赢恒生指数及恒生科技指数涨幅。","market":"hk","thumbnail":"https://img.zhitongcaijing.com/image/20250618/20250618174252_12407.png?x-oss-process=image/format,jpg/quality,q_60","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20250618/20250618174252_12407.png?x-oss-process=image/format,jpg/quality,q_60"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1306772.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["02315","BK1161"],"gpt_icon":0},{"id":"2544968317","title":"百奥赛图-B06月17日主力净流出39.2万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2544968317","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544968317?lang=zh_cn&edition=full","pubTime":"2025-06-17 16:15","pubTimestamp":1750148110,"startTime":"0","endTime":"0","summary":"06月17日, 百奥赛图-B股价跌2.57%，报收20.85元，成交金额720.8万元，换手率0.30%，振幅8.18%，量比0.47。百奥赛图-B今日主力资金净流出39.2万元，上一交易日主力净流入172万元。该股近5个交易日上涨5.30%，主力资金累计净流出27.8万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入463.5万元，其中净流入天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250617172535a4adfb23&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250617172535a4adfb23&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02315"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.bbctg.com.cn","stockEarnings":[{"period":"1week","weight":-0.0447},{"period":"1month","weight":-0.0876},{"period":"3month","weight":0.6945},{"period":"6month","weight":1.528},{"period":"1year","weight":1.7248},{"period":"ytd","weight":1.3882}],"compareEarnings":[{"period":"1week","weight":0.0132},{"period":"1month","weight":0.013},{"period":"3month","weight":0.1275},{"period":"6month","weight":0.255},{"period":"1year","weight":0.3231},{"period":"ytd","weight":0.2065}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"百奥赛图（北京）医药科技股份有限公司是一家主要从事药物开发业务及临床前研究的公司。该公司通过五个分部开展业务。基因编辑服务分部提供基于动物和细胞的定制化基因编辑服务。临床前药理药效评估分部提供用于药物疗效和毒性评估的临床前药理学服务。模式动物销售分部培育和销售外用和内用模式动物。抗体开发分部利用抗体发现平台识别有可能成为候选药物的抗体。创新药开发分部研发创新药，专注肿瘤学和自身免疫性疾病治疗。","exchange":"SEHK","name":"百奥赛图-B","nameEN":"BIOCYTOGEN-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"百奥赛图-B(02315)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供百奥赛图-B(02315)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"百奥赛图-B,02315,百奥赛图-B股票,百奥赛图-B股票老虎,百奥赛图-B股票老虎国际,百奥赛图-B行情,百奥赛图-B股票行情,百奥赛图-B股价,百奥赛图-B股市,百奥赛图-B股票价格,百奥赛图-B股票交易,百奥赛图-B股票购买,百奥赛图-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"百奥赛图-B(02315)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供百奥赛图-B(02315)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}